Molecular pathways: Harnessing E2F1 regulation for prosenescence therapy in p53-defective cancer cells.




Laine A, Westermarck J

2014

 Clinical Cancer Research

20

14

3644

3650

7

1078-0432

DOIhttps://doi.org/10.1158/1078-0432.CCR-13-1942




Last updated on 26/11/2024 09:19:40 PM